Your browser doesn't support javascript.
loading
PsyCog: A computerised mini battery for assessing cognition in psychosis.
Gifford, George; Cullen, Alexis E; Vieira, Sandra; Searle, Anja; McCutcheon, Robert A; Modinos, Gemma; Stone, William S; Hird, Emily; Barnett, Jennifer; van Hell, Hendrika H; Catalan, Ana; Millgate, Edward; Taptiklis, Nick; Cormack, Francesca; Slot, Margot E; Dazzan, Paola; Maat, Arija; de Haan, Lieuwe; Facorro, Benedicto Crespo; Glenthøj, Birte; Lawrie, Stephen M; McDonald, Colm; Gruber, Oliver; van Amelsvoort, Thérèse; Arango, Celso; Kircher, Tilo; Nelson, Barnaby; Galderisi, Silvana; Bressan, Rodrigo A; Kwon, Jun Soo; Weiser, Mark; Mizrahi, Romina; Sachs, Gabriele; Kirschner, Matthias; Reichenberg, Abraham; Kahn, René; McGuire, Philip.
Afiliação
  • Gifford G; University of Oxford, Oxford, UK.
  • Cullen AE; Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, KCL, London, UK.
  • Vieira S; Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Sweden.
  • Searle A; Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • McCutcheon RA; Cambridge Cognition Ltd, Cambridge, UK.
  • Modinos G; University of Oxford, Oxford, UK.
  • Stone WS; Oxford Health NHS Foundation Trust, Oxford, UK.
  • Hird E; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, KCL, London, UK.
  • Barnett J; Harvard Medical School Department of Psychiatry at the Beth Israel Deaconess Medical Center and the Massachusetts Mental Health Center, United States of America.
  • van Hell HH; Institute of Cognitive Neuroscience, UCL, London, UK.
  • Catalan A; Cambridge Cognition Ltd, Cambridge, UK.
  • Millgate E; Department of Psychiatry, University of Cambridge, Cambridge, UK.
  • Taptiklis N; University Medical Center, Division of Neurosciences, Department of Psychiatry, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.
  • Cormack F; Basurto University Hospital, Bilbo, Bizkaia, Spain.
  • Slot ME; Cambridge Cognition Ltd, Cambridge, UK.
  • Dazzan P; Cambridge Cognition Ltd, Cambridge, UK.
  • Maat A; Cambridge Cognition Ltd, Cambridge, UK.
  • de Haan L; University Medical Center, Division of Neurosciences, Department of Psychiatry, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.
  • Facorro BC; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, KCL, London, UK.
  • Glenthøj B; University Medical Center, Division of Neurosciences, Department of Psychiatry, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.
  • Lawrie SM; Amsterdam UMC, University of Amsterdam, Psychiatry, Department Early Psychosis, Meibergdreef 9, Amsterdam, the Netherlands.
  • McDonald C; CIBERSAM, Centro Investigación Biomédica en Red Salud Mental, Sevilla, Spain.
  • Gruber O; University Hospital Virgen del Rocio, IBIS-CSIC, Department of Psychiatry, School of Medicine, University of Sevilla, Sevilla, Spain.
  • van Amelsvoort T; Centre for Neuropsychiatric Schizophrenia Research (CNSR), Centre for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Mental Health Centre Glostrup, University of Copenhagen, Glostrup, Denmark.
  • Arango C; University of Copenhagen, Faculty of Health and Medical Sciences, Dept. of Clinical Medicine, Copenhagen, Denmark.
  • Kircher T; Division of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK.
  • Nelson B; Centre for Neuroimaging & Cognitive Genomics (NICOG), Galway Neuroscience Centre, University of Galway, H91 TK33 Galway, Ireland.
  • Galderisi S; Section for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University, Heidelberg, Germany.
  • Bressan RA; Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, the Netherlands.
  • Kwon JS; Servicio de Psiquiatría del Niño y del Adolescente, Hospital General Universitario Gregorio Marañon, Universidad Complutense Madrid, Spain, Centro de Investigación Biomédica en Red de Salud Mental, Madrid, Spain.
  • Weiser M; Dept of Psychiatry, University of Marburg, Rudolf-Bultmann-Straße 8, D-35039 Marburg, Germany.
  • Mizrahi R; Orygen, 35 Poplar Road, Parkville, Victoria, Melbourne, Australia.
  • Sachs G; Centre for Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
  • Kirschner M; Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, Largo Madonna delle Grazie, 80138 Naples, Italy.
  • Reichenberg A; Department of Psychiatry, Interdisciplinary Lab for Clinical Neurosciences (LiNC), Universidade Federal de Sao Paulo (UNIFESP), Sao Paulo, Brazil.
  • Kahn R; Department of Psychiatry, Sheba Medical Center, Tel Hashomer 52621, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • McGuire P; Department of Psychiatry, McGill University, Montreal, Canada.
Schizophr Res Cogn ; 37: 100310, 2024 Sep.
Article em En | MEDLINE | ID: mdl-38572271
ABSTRACT
Despite the functional impact of cognitive deficit in people with psychosis, objective cognitive assessment is not typically part of routine clinical care. This is partly due to the length of traditional assessments and the need for a highly trained administrator. Brief, automated computerised assessments could help to address this issue. We present data from an evaluation of PsyCog, a computerised, non-verbal, mini battery of cognitive tests. Healthy Control (HC) (N = 135), Clinical High Risk (CHR) (N = 233), and First Episode Psychosis (FEP) (N = 301) participants from a multi-centre prospective study were assessed at baseline, 6 months, and 12 months. PsyCog was used to assess cognitive performance at baseline and at up to two follow-up timepoints. Mean total testing time was 35.95 min (SD = 2.87). Relative to HCs, effect sizes of performance impairments were medium to large in FEP patients (composite score G = 1.21, subtest range = 0.52-0.88) and small to medium in CHR patients (composite score G = 0.59, subtest range = 0.18-0.49). Site effects were minimal, and test-retest reliability of the PsyCog composite was good (ICC = 0.82-0.89), though some practice effects and differences in data completion between groups were found. The present implementation of PsyCog shows it to be a useful tool for assessing cognitive function in people with psychosis. Computerised cognitive assessments have the potential to facilitate the evaluation of cognition in psychosis in both research and in clinical care, though caution should still be taken in terms of implementation and study design.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Schizophr Res Cogn Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Schizophr Res Cogn Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos